Stockreport

Here's Why CRISPR Stocks Fell in January [The Motley Fool]

Intellia Therapeutics, Inc.  (NTLA) 
Last intellia therapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intelliatx.com/investor-overview
PDF Spurred by promising clinical results in an important trial, each of the three major CRISPR stocks had a great performance in the second half of 09. Unfortunately, they [Read more]